Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve): Observations from a retrospective, observational study on patients with SLE in Russia and Saudi Arabia | GSK | Ongoing | Belimumab | 4 | OneCDP 215 | King Fahad Medical City (Riyadh),Aseer Central Hospital (Abha),King Khalid University Hospital (Riyadh),King Fahad specialized hospital (Tabuk) |
| The Effect of Synbiotic Consumption on Glycemic, Inflammatory Markers and Body Composition on Prediabetic and Diabetic Patients: A Double Blinded Randomized Control Trial | Imam Abdulrahman Bin Faisal University | Ongoing | Synbiotics (Viridian Nutrition) | 3 | IRB-2019-03-227 | King Fahad University Hospital (Al-Khobar) , Family and Community Medicine Center (Dammam) |
| ABROCITINIB EXPANDED ACCESS PROTOCOL FOR THE TREATMENT OF ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | Pfizer | Terminated | Abrocitinib | 3 | B7451064 | King Abdulaziz University Hospital (Jeddah) |
| A randomized, double-blind, placebo controlled study assessing the long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate to severe asthma | Sanofi Aventis | Ongoing | Dupilumab | 4 | LPS16676 | King Saud Medical City (Riyadh),King Abdullah Medical City (Makkah) |
| Effectiveness of Dextrose 5% In Water Local Injection Into Spastic Muscles to manage focal Spasticity (D5W/ Spasticity ). | PI-initiated | Rejected | DEXTROSE 5% IN WATER | 4 | TU022144 | King Fahad specialized hospital (Tabuk) |
| The effects of alpha lipoic acid supplementation on nerve conduction study in patients with diabetic neuropathy | EVA PHARMA | Rejected | ALPHA LIPOIC ACID | 4 | IRB-2022-5 | King Fahad University Hospital (Al-Khobar) |
| Transthyretin Amyloidosis Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin Gene Mutations or Wild-Type Transthyretin Amyloidosis | Pfizer | Terminated | Tafamidis | 4 | B3461001 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease | Agios Pharmaceuticals, Inc. | Ongoing | Mitapivat | 2/3 | AG348-C-020 | King Khalid University Hospital (Riyadh) |
| Prospective, observational study in sickle cell disease patients on crizanlizumab treatment in Middle East countries and India. | Novartis | Ongoing | crizanlizumab | 4 | CSEG101AIC05 | Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia |
| A PHASE II, SINGLE-ARM STUDY OF ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER WHO HAVE NOT PROGRESSED AFTER PLATINUM-BASED CONCURRENT CHEMORADIATION | Roche | Ongoing | ATEZOLIZUMAB (TECENTRIQ) | 2 | MO43156 | King Fahad Specialist Hospital (Dammam) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.